Changes in corneal parameters at confocal microscopy in treated glaucoma patients

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 1037-1042

  Ranno, Stefano ^a   Fogagnolo, Paolo ^b   Rossetti, Luca ^a   Orzalesi, Nicola ^a   Nucci, Paolo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

Author keywords

Confocal microscopy; Cornea; Endothelial cells; Glaucoma; Sub basal nerves

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROSTAGLANDIN DERIVATIVE;

ADULT; AGED; ARTICLE; CELL COUNT; CELL DENSITY; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORNEA; CORNEA ENDOTHELIUM; ENDOTHELIUM CELL; FEMALE; HUMAN; MALE; NERVE FIBER; OPEN ANGLE GLAUCOMA; RATING SCALE;

EID: 79961223212     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S22874     Document Type: Article

References (28)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
2. Baudouin C, Liang H, Hamard P, et al. The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology. 2008;115:109-115.
3. Wilson LA. To preserve or not to preserve, is that the question? Br J Ophthalmol. 1996;80:583-584.
4. Wilson FM. Adverse external ocular effects of topical ophthalmic medications. Surv Ophthalmol. 1979;24:57-88.
5. Sherwood MB, Grierson I, Millar L, et al. Long-term morphologic effects of antiglaucomatous drugs on the conjunctiva and Tenon's capsule in glaucoma patients. Ophthalmology. 1989;96:327-335.
6. Herreras JM, Pastor JC, Calonge M, et al. Ocular surface alteration after long-term treatment with an antiglaucomatous drug. Ophthalmology. 1992;99:1082-1088.
7. Ishibashi T, Yokoi N, Kinoshita S. Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride. J Glaucoma. 2003;12:486-490.
8. Baudouin C. Side effects of antiglaucomatous drugs on the ocular surface. Curr Opin Ophthalmol. 1996;7:80-86.
9. Shimazaki J, Hanada K, Yagi Y, et al. Changes in ocular surface caused by antiglaucomatous eye drops: prospective, randomised study for the comparison of 0.5% timolol vs 0.12% unoprostone. Br J Ophthalmol. 2000;84:1250-1254.
10. Wu KY, Wang HZ, Hong SJ. Cellular cytotoxicity of antiglaucoma drugs in cultured corneal endothelial cells. Kaohsiung J Med Sci. 2007;23:105-111.
11. Ayaki M, Noda Y, Yaguchi S, et al. Cytotoxicity of antiglaucoma ophthalmic solutions for human corneal endothelial cells. Nippon Ganka Gakkai Zasshi. 2009;113:576-582. Japanese.
12. Villani E, Galimberti D, Viola F, Mapelli C, Ratiglia R. The cornea in Sjogren's syndrome: an in vivo confocal study. Invest Ophthalmol Vis Sci. 2007;48:2017-2022.
13. Villani E, Galimberti D, Viola F, Mapelli C, Del Papa N, Ratiglia R. Corneal involvement in rheumatoid arthritis: an in vivo confocal study. Invest Ophthalmol Vis Sci. 2008;49:560-564.
14. De Cillà S, Ranno S, Carini E, et al. Corneal subbasal nerves changes in patients with diabetic retinopathy: an in vivo confocal study. Invest Ophthalmol Vis Sci. 2009;50:5155-5158.
15. Ceresara G, Fogagnolo P, De Cillà S, et al. Corneal involvement in Crohn's disease: an in vivo confocal microscopy study. Cornea. 2011;30:136-142.
16. European Glaucoma Society. Terminology and guidelines for glaucoma. Savona, Italy: Editrice Dogma SRL; 2008.
17. Stave J, Zinser G, Grummer G, Guthoff R. Modified Heidelberg retinal tomography HRT: initial result of in vivo presentation of corneal structures. Ophthalmologe. 2002;99:276-280. German.
18. Oliveira-Soto L, Efron N. Morphology of corneal nerves using confocal microscopy. Cornea. 2001;20:374-384.
19. Fleiss JJ, Choen J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas. 1973;33:613-619.
20. Landis JR, Koch GG. The measurements of observer agreement for categorical data. Biometrics. 1977;33:159-174.
21. Brandt JD, Wittpen JR, Katz LJ, et al. Conjunctival impression cytology in patients with glaucoma using long-term topical medication. Am J Ophthalmol. 1993;112:297-301.
22. Becquet F, Goldschild M, Moldovan MS. Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. Curr Eye Res. 1998;17:419-425.
23. De Saint JM, Debbash F, Brignole P. Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells. Curr Eye Res. 2000;20:85-94.
24. Grant R, Ajello M, Vlass E. Salt water or high tech? A look at two new rising solutions for contact lenses. Optician. 1996;212:38-41.
25. Zhang M, Chen J, Luo L, Xiao Q, Sun M, Liu Z. Altered corneal nerves in aqueous tear deficiency viewed by in vivo confocal microscopy. Cornea. 2005;24:818-824.
26. Martone G, Frezzotti P, Tosi GM, et al. An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology. Am J Ophthalmol. 2009;147:725-735.
27. Ayaki M, Yaguchi S, Iwasawa A, Koide R. Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells. Clin Experiment Ophthalmol. 2008;36:553-559.
28. Waltman SR, Yarian D, Hart W, et al. Corneal endothelial changes with long-term topical epinephrine therapy. Arch Ophthalmol. 1977;95:1357-1358.